EunetHTA has developed several tools to support the conduciton of Joint Assessments, but also to facilitate the collection of evidence from the companies.
A joint assessment is a structured information for rapid or full/comprehensive HTAs which is the output of joint production in which 2 or more countries and/or organisations work together to prepare shared products or agreed outcomes (Based on definitions from the HTA Network Strategy (page 24) and the EUnetHTA Recommendations (page 6, footnote 8))
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions and numerous educational symposia, workshops and issue panels. Through the links below you will be able to access the presentations covering EUnetHTA activities or topics of interest/collaboration within EUnetHTA.
This document is the comments provided during public consultation of Draft Background Review on Relative Effectiveness Assessment of Pharmaceuticals, carried out by the WP5 in JA1.
